BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 25604080)

  • 1. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
    Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
    Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells.
    Kennedy A; Schmidt EM; Cribbs AP; Penn H; Amjadi P; Syed K; Read JE; Green P; Gregory B; Brennan FM
    Eur J Immunol; 2014 Oct; 44(10):2968-78. PubMed ID: 25042153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
    Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
    Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction.
    Constantin A; Loubet-Lescoulié P; Lambert N; Yassine-Diab B; Abbal M; Mazières B; de Préval C; Cantagrel A
    Arthritis Rheum; 1998 Jan; 41(1):48-57. PubMed ID: 9433869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway.
    Cribbs AP; Kennedy A; Penn H; Read JE; Amjadi P; Green P; Syed K; Manka SW; Brennan FM; Gregory B; Williams RO
    Arthritis Rheumatol; 2014 Sep; 66(9):2344-54. PubMed ID: 24891289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.
    Bonelli M; Göschl L; Blüml S; Karonitsch T; Hirahara K; Ferner E; Steiner CW; Steiner G; Smolen JS; Scheinecker C
    Rheumatology (Oxford); 2016 Apr; 55(4):710-20. PubMed ID: 26672908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis.
    Ryder LR; Woetmann A; Madsen HO; Ødum N; Ryder LP; Bliddal H; Danneskiold-Samsøe B; Ribel-Madsen S; Bartels EM
    Scand J Rheumatol; 2010 Aug; 39(4):279-86. PubMed ID: 20476861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated Expression of microRNA-16 Correlates with Th17/Treg Cell Imbalance in Patients with Rheumatoid Arthritis.
    Wu YH; Liu W; Xue B; Zhang L; Liu XY; Liu B; Wang Y; Cai Y; Duan R
    DNA Cell Biol; 2016 Dec; 35(12):853-860. PubMed ID: 27875659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment.
    Avdeeva A; Rubtsov Y; Dyikanov D; Popkova T; Nasonov E
    Biochimie; 2020 Jul; 174():9-17. PubMed ID: 32275944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
    Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
    Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production.
    Morita Y; Fukazawa T; Hirashima M; Kaga K; Kusaoi M; Morita T; Touyama S; Morita K; Takasaki Y; Hashimoto H
    Scand J Rheumatol; 2006; 35(4):268-72. PubMed ID: 16882589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helios Enhances Treg Cell Function in Cooperation With FoxP3.
    Takatori H; Kawashima H; Matsuki A; Meguro K; Tanaka S; Iwamoto T; Sanayama Y; Nishikawa N; Tamachi T; Ikeda K; Suto A; Suzuki K; Kagami S; Hirose K; Kubo M; Hori S; Nakajima H
    Arthritis Rheumatol; 2015 Jun; 67(6):1491-502. PubMed ID: 25733061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease.
    Jia L; Zhu L; Wang JZ; Wang XJ; Chen JZ; Song L; Wu YJ; Sun K; Yuan ZY; Hui R
    Atherosclerosis; 2013 Jun; 228(2):346-52. PubMed ID: 23566804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of methotrexate on regulation for the number of regulatory T cells and expression of Foxp3 in psoriasis].
    Kuang Y; Zhang H; Zhu W; Wu L; Chen W; Lu Y; Qin Q; Jia X; Liao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 43(8):835-842. PubMed ID: 30197310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
    Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
    Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis.
    Behrens F; Himsel A; Rehart S; Stanczyk J; Beutel B; Zimmermann SY; Koehl U; Möller B; Gay S; Kaltwasser JP; Pfeilschifter JM; Radeke HH
    Ann Rheum Dis; 2007 Sep; 66(9):1151-6. PubMed ID: 17392348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro.
    Oh BR; Suh DH; Bae D; Ha N; Choi YI; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Arthritis Res Ther; 2017 Jul; 19(1):154. PubMed ID: 28673326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis.
    Appel H; Wu P; Scheer R; Kedor C; Sawitzki B; Thiel A; Radbruch A; Sieper J; Syrbe U
    J Rheumatol; 2011 Nov; 38(11):2445-51. PubMed ID: 21921098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.